SiO2 launches unbreakable blood collection tube for genetic diagnostics

LabPulse.com staff writers
Dec 3, 2019
2019 05 15 22 45 9236 Lab Blood Dna 400

SiO2 Materials Science announced the launch of its unbreakable Synergy blood collection tube for use in genetic diagnostics.

The tube was designed for use in cell-free DNA (cfDNA), cfRNA, and genomic DNA (gDNA) pairing using one sample. According to the company, it optimizes nucleic acid recovery and cancer tumor cells from the point of blood draw.

The tube is being positioned as an alternative to plastic or glass products. It has an "oxygen and moisture barrier like glass, but it is lightweight and unbreakable like plastic," which allows for greater vacuum retention, longer sample preservation, and safer shipping, the company explained in a white paper. Shelf life is two to three times longer than with plastics, according to SiO2.

Latest in Molecular Diagnostics
Dna Sequencing Social
Labcorp launches liquid biopsy test for oncology
June 1, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
May 11, 2023
T Cell Social
Single-cell RNA sequencing data reveals T cells linked to cancer immunotherapy resistance
May 30, 2023
Colorectal Cancer Social
Bacteria vary between early- and late-onset colorectal cancer tumors: Study
May 30, 2023
Related Stories
2020 04 14 17 10 6379 Test Tubes Rd Lab 400
Influenza
Longhorn to partner with SiO2
2019 08 12 20 23 3708 Lab Blood Centrifuge 400
Molecular Diagnostics
Phase Scientific highlights clinical results at AACR
2020 01 02 21 33 6724 Hardy Diagnostics Medical Transport Medium 20200102214003
510(k)
Hardy rolls out line of specimen transport tubes
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Molecular Diagnostics
Labcorp launches liquid biopsy test for oncology
The test, called Labcorp Plasma Focus, enables treating oncologists to evaluate circulating cell-free DNA released by tumor cells.
June 1, 2023
Dna Sequencing Social
Deep sequencing captures genetic variants for vascular anomalies
Deep sequencing in a study identified extremely low levels of previously undescribed genetic variants in patients with life-threatening vascular anomalies, improving their treatment.
June 1, 2023
Dna Sequencing2 Social(1)
Single-cell RNA sequencing data reveals T cells linked to cancer immunotherapy resistance
Scientists at the University of Texas MD Anderson Cancer Center have provided a new explanation for why checkpoint inhibitors are ineffective in some patients.
May 30, 2023
T Cell Social
Bacteria vary between early- and late-onset colorectal cancer tumors: Study
Bacteria types vary widely between early- versus late-onset colorectal cancer tumors, providing clues to the disease’s increase in younger people, according to a study.
May 30, 2023
Colorectal Cancer Social
Eurobio Scientific obtains IVDR CE markings for PCR tests
The CE markings enable the firm to market three of its PCR tests as class C in vitro diagnostic medical devices for the detection of infectious diseases.
May 24, 2023
Business Regulation Graphic Social Resized
Illumina CEO remains on the board, chairman is voted out
Activist investor Carl Icahn, in a proxy fight, had urged the shareholders to remove the chairman and CEO from the board.
May 26, 2023
Sequencing Dna Rna Social
Agilent Technologies fiscal Q2 revenues rise 7%; firm trims full-year estimates
Diagnostics and Genomics Group revenues were $362 million, up 1% year-over-year compared to $358 million.
May 24, 2023
Dna Genome Gene Targeted Social
Domus Diagnostics gets $2.4M NIH grant to develop at-home molecular test
The award, granted as part of the NIH Rapid Acceleration of Diagnostics (RADx) Tech program, will support accelerated validation and scaling of a testing platform to prepare it for a clinical trial.
May 24, 2023
Money Bag Grant Award Social
BPGbio expands agreement with DoD on AI-guided breast cancer diagnostic panel
The diagnostic panel was developed using artificial intelligence to identify patients diagnosed with ER+ breast cancer who do not respond to hormone therapy, to guide caregivers to appropriate treatment options.
May 24, 2023
Breast Mammo Social
T2 Biosystems submits FDA 510(k) premarket notification for biothreat panel
The panel is a fully-automated, direct-from-blood test designed to run on the T2 Biosystem’s FDA-cleared T2Dx Instrument and simultaneously detects six pathogens identified as threats by the CDC.
May 23, 2023
Fda Button Social
A. Menarini launches full automated MDx platform at WorldLab-EuroMedLab
The system, Prime MDx, is an all-in-one, sample-to-result platform designed to allows users to process a variety of sample types through real-time polymerase chain reaction (PCR), the Florence, Italy-based firm said.
May 23, 2023
Artificial Intelligence Ai Social
DNA Script announces broad launch of DNA printing platform
The Syntax platform allows scientists working in their laboratories to synthesize up to 96 highly accurate, ready-to-use DNA oligos with maximum lengths of up to 120 nucleotides in less than 24 hours, DNA Script said.
May 22, 2023
Dna Sequencing Social
Page 1 of 180
Next Page